Oceanside, CA, United States of America

Nianchun Ma

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nianchun Ma: Innovator in Drug Delivery Systems

Introduction

Nianchun Ma, based in Oceanside, California, is a distinguished inventor known for his contributions to the field of drug delivery systems. With a focus on innovative solutions for medical challenges, Ma's work aims to enhance therapeutic outcomes for patients.

Latest Patents

Nianchun Ma holds a patent for drug carriers that encompass a cationic polymeric carrier, targeting agent, and therapeutic agent. This groundbreaking invention provides compositions capable of inhibiting fibrosis within target organs or tissues and impeding the growth of cancer cells. His patent represents a significant advancement in the realm of therapeutic applications.

Career Highlights

Ma works at Nitto Denko Corporation, where he has leveraged his expertise in developing innovative medical technologies. His dedication to research and development has positioned him as a pivotal figure in pharmaceutical sciences, contributing to enhanced patient care through effective drug delivery methods.

Collaborations

Throughout his career, Nianchun Ma has collaborated with esteemed colleagues, including Yoshiro Niitsu and Lei Yu. These partnerships have facilitated the exchange of ideas and innovation, furthering the development of effective drug delivery systems that benefit a broader patient population.

Conclusion

Nianchun Ma's inventive spirit and dedication to improving therapeutic strategies underscore the importance of innovation in medicine. His patent for drug carriers exemplifies how targeted delivery systems can revolutionize treatments for serious health conditions, such as cancer and organ fibrosis. Ma continues to inspire others in his field, demonstrating the profound impact of researchers and inventors on patient wellbeing and medical advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…